SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GLGC Gene Logic
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (45)5/13/1999 10:41:00 AM
From: Steve Push  Read Replies (1) of 360
 
Richard,

At the present time, we are not aware of any intellectual property that would limit our freedom to commercialize the Flow-thru Chip(TM) probe array.

This message contains a forward-looking statement about our ability to commercialize our Flow-thru Chip without infringing the patents of others. Such statements reflect management's current view of future events. Actual results may differ materially from these projections because of a number of factors, including company's ability to enforce its intellectual property rights and the impact of the intellectual property rights of others. There can be no assurance that, in the future, we will not discover that we are infringing someone else's intellectual property rights. These risk factors and others are more fully described in the company's Annual Report on Form 10-K for the year ended December 31, 1998, and other documents filed with the Securities and Exchange Commission.

Steve Push
VP, Corporate Communications
Gene Logic Inc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News